KLACID TABLET 250 mg Singapore - English - HSA (Health Sciences Authority)

klacid tablet 250 mg

abbott laboratories (singapore ) private limited - clarithromycin - tablet, film coated - 250 mg - clarithromycin 250 mg

Klacid 250mg Film-Coated Tablets Malta - English - Medicines Authority

klacid 250mg film-coated tablets

mylan products limited - clarithromycin - coated tablet - clarithromycin 250 mg - antibacterials for systemic use

Klacid 500mg Film-Coated Tablets Malta - English - Medicines Authority

klacid 500mg film-coated tablets

mylan products limited - clarithromycin - coated tablet - clarithromycin 500 mg - antibacterials for systemic use

Klacid Once daily New Zealand - English - Medsafe (Medicines Safety Authority)

klacid once daily

viatris limited - clarithromycin 500mg;  ;  ;   - modified release tablet - 500 mg - active: clarithromycin 500mg       excipient: citric acid ethanol hypromellose lactose monohydrate macrogol 400 macrogol 8000 magnesium stearate povidone purified talc purified water quinoline yellow sodium alginate sodium calcium alginate sorbic acid stearic acid titanium dioxide

ADVAGRAF XL tacrolimus 5 mg prolonged-release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

advagraf xl tacrolimus 5 mg prolonged-release capsule blister pack

astellas pharma australia pty ltd - tacrolimus, quantity: 5 mg - capsule, modified release - excipient ingredients: lactose monohydrate; titanium dioxide; hypromellose; sodium lauryl sulfate; iron oxide red; magnesium stearate; iron oxide yellow; ethylcellulose; gelatin; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

ADVAGRAF XL tacrolimus 1 mg prolonged-release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

advagraf xl tacrolimus 1 mg prolonged-release capsule blister pack

astellas pharma australia pty ltd - tacrolimus, quantity: 1 mg - capsule, modified release - excipient ingredients: hypromellose; iron oxide yellow; gelatin; sodium lauryl sulfate; titanium dioxide; ethylcellulose; iron oxide red; magnesium stearate; lactose monohydrate; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.

ADVAGRAF XL  tacrolimus 0.5 mg prolonged-release capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

advagraf xl tacrolimus 0.5 mg prolonged-release capsule blister pack

astellas pharma australia pty ltd - tacrolimus, quantity: 0.5 mg - capsule, modified release - excipient ingredients: iron oxide yellow; hypromellose; iron oxide red; titanium dioxide; lactose monohydrate; ethylcellulose; magnesium stearate; sodium lauryl sulfate; gelatin; hyprolose; butan-1-ol; purified water; industrial methylated spirit; simethicone; lecithin; ethanol; shellac; strong ammonia solution; sulfuric acid - advagraf xl is indicated for use as an adjunct to liver, kidney, lung or heart allograft transplantation in adults and children.